Log in

NYSEAMERICAN:NAVBNavidea Biopharmaceuticals SEC Filings & 10K Form

$2.85
+0.18 (+6.74 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.60
Now: $2.85
$2.86
50-Day Range N/A
52-Week Range
$0.49
Now: $2.85
$3.50
Volume743,300 shs
Average Volume1.03 million shs
Market Capitalization$61.69 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

SEC Filings

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) SEC Filings

DateFilerForm TypeView
06/04/2020
3:18 PM
Navidea Biopharmaceuticals (Issuer)
Rosol Michael Stanley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2020
3:18 PM
Latkin Jed (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2020
3:15 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2020
4:25 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
3:52 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
2:58 PM
Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
4:30 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
4:29 PM
Navidea Biopharmaceuticals (Filer)
Form 424B5
01/09/2020
11:15 PM
Navidea Biopharmaceuticals (Filer)
Form EFFECT
12/31/2019
3:06 PM
Navidea Biopharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/30/2019
4:22 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2019
3:32 PM
Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
Form SC 13D/A
12/11/2019
3:05 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2019
10:11 AM
Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
3:22 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
3:06 PM
Navidea Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2019
6:45 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
3:05 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
3:06 PM
Navidea Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
3:14 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
7:05 AM
Navidea Biopharmaceuticals (Filer)
Form DEFA14A
06/28/2019
7:00 AM
Navidea Biopharmaceuticals (Filer)
Form DEF 14A
06/24/2019
4:15 PM
Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
Form SC 13D
06/24/2019
3:36 PM
ARMISTICE CAPITAL, LLC (Filed by)
Navidea Biopharmaceuticals (Subject)
Form SC 13G
06/21/2019
7:50 PM
Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
9:00 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
8:47 AM
Navidea Biopharmaceuticals (Filer)
Form 424B5
06/13/2019
4:22 PM
Navidea Biopharmaceuticals (Filer)
Form 424B5
06/07/2019
3:05 PM
Latkin Jed (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
3:10 PM
Navidea Biopharmaceuticals (Issuer)
Rouan Sarah Kathryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:06 PM
Bruck Claudine (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:04 PM
Latkin Jed (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
3:06 PM
Navidea Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2019
3:05 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2019
3:10 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2019
3:05 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2019
4:36 PM
Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2019
5:09 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2019
4:27 PM
Navidea Biopharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2019
3:11 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2019
6:00 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2019
3:53 PM
Navidea Biopharmaceuticals (Issuer)
RICE YEHUDA MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2019
3:15 PM
Navidea Biopharmaceuticals (Issuer)
Rouan Sarah Kathryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
5:22 PM
Latkin Jed (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
7:01 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
3:29 PM
Navidea Biopharmaceuticals (Issuer)
Rosol Michael Stanley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
1:22 PM
Navidea Biopharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/19/2018
9:34 AM
Navidea Biopharmaceuticals (Issuer)
Rosol Michael Stanley (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/12/2018
9:36 AM
Navidea Biopharmaceuticals (Issuer)
Rouan Sarah Kathryn (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2018
9:16 AM
Cutler Adam D. (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/30/2018
1:35 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2018
4:17 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
1:46 PM
Navidea Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
3:24 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2018
9:38 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
3:51 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
6:30 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2018
3:23 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2018
6:07 PM
Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2018
4:29 PM
Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
Form SC 13G
09/17/2018
4:25 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2018
3:01 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2018
6:30 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2018
8:01 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
6:38 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
4:04 PM
Navidea Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2018
7:45 PM
Navidea Biopharmaceuticals (Filer)
Form DEFA14A
07/09/2018
4:20 PM
Navidea Biopharmaceuticals (Filer)
Form DEF 14A
05/31/2018
10:48 AM
Navidea Biopharmaceuticals (Filer)
Form SD
Specialized Disclosure Report  
05/09/2018
3:50 PM
Navidea Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
4:14 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2018
1:32 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2018
4:20 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2018
9:43 AM
Bruck Claudine (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
3:19 PM
Navidea Biopharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2018
5:02 PM
Bruck Claudine (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/08/2018
4:26 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2018
9:05 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2018
4:40 PM
Navidea Biopharmaceuticals (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2018
4:38 PM
Navidea Biopharmaceuticals (Issuer)
RICE YEHUDA MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2018
4:37 PM
Greene Mark I (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2018
4:35 PM
Cope Frederick O (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2017
11:15 PM
Navidea Biopharmaceuticals (Filer)
Form EFFECT
12/15/2017
3:19 PM
Navidea Biopharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/15/2017
3:17 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.